GeneReach Biotechnology Financial Health
How is GeneReach Biotechnology's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4171's short term assets (NT$1.3B) exceed its short term liabilities (NT$591.4M).
Long Term Liabilities: 4171's short term assets (NT$1.3B) exceed its long term liabilities (NT$141.2M).
Debt to Equity History and Analysis
Debt Level: 4171 has more cash than its total debt.
Reducing Debt: 4171's debt to equity ratio has reduced from 99.6% to 5.7% over the past 5 years.
Debt Coverage: 4171's debt is well covered by operating cash flow (836.7%).
Interest Coverage: 4171's interest payments on its debt are well covered by EBIT (65.7x coverage).